basic FUNCTION
| mediating putatively cell-cell interaction in the heart |
|
may act as a negative regulator of neural cell growth |
|
playing an important role in cell recognition and adhesion |
|
may modulate cell-matrix adhesion in basal keratinocytes as well as invasive potency in cutaneous squamous carcinoma by regulating surface level of beta1 integrin (ITGB1) |
|
may have a role in hormone and drug-induced changes in bone morphology and pathology |
|
may play an important role in controlling tissue cellularity during vascular remodeling |
|
protects endothelial cells from oxidative stress-induced apoptosis |
|
negative regulator for gallbladder cancer invasion |
|
adhesive capacity is necessary to regulate neurite iutgrowth from CDH13-expressing neurons |
|
is a novel component of insulin granules, suggesting that CDH13 contributes to the regulation of insulin secretion independently of direct interactions with ADIPOQ |
|
CDH13 expression modulates signalling and functional responses of endothelial cells (EC) to insulin |
|
translocation to cell-cell contacts is sensitive to the activity status of EGFR, requires lipid raft domain integrity and actin filament polymerization, and crucial intracellular signalling mediators include RAC1 and MAPK14 |
|
role for CDH13 in limb revascularization and it is essential for mediating the vascular actions of adiponectin |
|
role of CDH13 in regulation of endothelial permeability and its possible engagement in endothelial dysfunction |
|
CDH13, GRM8, ANK2, SLC16A6, ARSG, RIMBP2 and DCLK1 having role in hearing function |
|
is involved in axonal pathway formation in the developing cortex |
|
is a negative regulator of inhibitory synapses in the hippocampus |
|
novel protective role for CDH13 in cortical neuron development |
|
is a novel positive regulator of autophagy and survival in smooth muscle cells (SMCs) |
|
is critical for inhibitory function of Golgi cells |